Mette Marie Hougaard Christensen

Author

Also Known As

Christensen, M. M. Hougaard, Christensen, Mette Marie, Kramers, C., M.M. Hougaard Christensen, M.M.H. Christensen, MM Hougaard Christensen, MMH Christensen, Mette M. Christensen, Mette M. H. Christensen, Mette M.H. Christensen

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital University of Southern Denmark University of California, San Francisco Aarhus University Hospital GTx (United States)

About

Mette Marie Hougaard Christensen is an author at Odense University Hospital specializing in pharmacology, medicine, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	167
2	Health Sciences	2	2	48
3	Engineering	1	1	56
4	Social Sciences	1	1	14
5	Biochemistry	1	1	22

Mette Marie Hougaard Christensen

Publications

920

Citations

H-Index

Page 1

	Year	Citations
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c Mette Marie Hougaard Christensen, Charlotte Brasch‐Andersen, Henrik Gréen, Pharmacogenetics and Genomics	2011	256
In Vivo Imaging of Human <sup>11</sup> C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses Lars Christian Gormsen, Elias Sundelin, Jonas Jensen, Journal of Nuclear Medicine	2016	136
A gene–gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin Mette Marie Hougaard Christensen, Rasmus S. Pedersen, Tore Bjerregaard Stage, Pharmacogenetics and Genomics	2013	76
Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes Tore Bjerregaard Stage, Mette Marie Hougaard Christensen, Niklas Rye Jørgensen, Bone	2018	67
Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers Mette Marie Hougaard Christensen, Kurt Højlund, Ole Hother‐Nielsen, European Journal of Clinical Pharmacology Molecular PharmacologyMedicineHealthy VolunteersPhysiologyClinical Pharmacology	2015	59
The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars Thomas Bo Jensen, Dorthe Bartels, Eva Aggerholm Sædder, European Journal of Clinical Pharmacology Preclinical TherapeuticsBiologic AgentEngineeringBioprospectingBiotechnology	2019	56
The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial Andreas James Thestrup Pedersen, Tore Bjerregaard Stage, Dorte Glintborg, Basic & Clinical Pharmacology & Toxicology	2017	52
Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial Mette Marie Hougaard Christensen, Kurt Højlund, Ole Hother‐Nielsen, Diabetologia ObesityMetabolic SyndromeDiabetes ManagementMedicineRandomised Trial	2015	34
Intake of<scp>S</scp>t<scp>J</scp>ohn's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone Tore Bjerregaard Stage, Rasmus S. Pedersen, Per Damkier, British Journal of Clinical Pharmacology	2014	34
The role of genetic variants in CYP2C8, LPIN1, PPARGC1A and PPARγ on the trough steady-state plasma concentrations of rosiglitazone and on glycosylated haemoglobin A1c in type 2 diabetes Tore Bjerregaard Stage, Mette Marie Hougaard Christensen, Søren Feddersen, Pharmacogenetics and Genomics	2013	34

Page 1